USFDA completed audit of Mexican plant: Dr Reddy's Laboratories
New Delhi: Drug major Dr Reddy's Laboratories on Friday said the US health regulator has completed audit of its API Cuernavaca Plant in Mexico.
"The audit of our API Cuernavaca plant in Mexico by the USFDA has been completed with zero observations," Dr Reddy's Laboratories (DRL) said in a BSE filing.
The stock was trading 0.96 per cent lower at Rs 447 on the BSE.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd